Expression of epidermal CAMP changes in parallel with permeability barrier status

Area of Science:

• Dermatology
• Immunology
• Biochemistry

Background:

• The skin's outer epidermis has two key defenses: a permeability barrier and antimicrobial defense.
• These functions share structural and biochemical traits, with antimicrobial peptides (AMPs) like mouse β-defensin 3 (mBD3), mouse cathelicidin antimicrobial peptide (mCAMP), and catestatin (Cst) found in the epidermis.
• mBD3 and mCAMP are released from epidermal lamellar bodies, contributing to barrier function.

Purpose of the Study:

• To investigate the co-regulation of epidermal permeability barrier and antimicrobial defense functions.
• To examine how alterations in barrier status affect the expression of mBD3, mCAMP, and Cst in mouse skin.

Main Methods:

• Immunohistochemical analysis of mouse skin samples with compromised or enhanced permeability barrier function.
• Assessment of mBD3, mCAMP, and Cst expression levels in relation to barrier status.

Main Results:

• Mouse cathelicidin antimicrobial peptide (mCAMP) expression positively correlated with barrier function, while catestatin (Cst) expression showed an inverse correlation.
• Mouse β-defensin 3 (mBD3) expression correlated with experimental barrier disruptions but not developmental changes.
• These findings suggest co-regulation between barrier homeostasis and specific antimicrobial peptides.

Conclusions:

• Cathelicidin and catestatin expression levels dynamically parallel changes in skin barrier status.
• The relationship between mBD3 expression and barrier function is less direct.
• These AMPs play a role in maintaining skin barrier integrity and defense.